Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bioyond

Request full access

Life-science lab automation robots and unattended intelligent lab platforms

Pudong, ChinaFounded 2021Robotics

About Bioyond

Shanghai Benyao Technology Co., Ltd., operating as Bioyond, is a life sciences company established in March 2021 with headquarters in Shanghai's Zhangjiang Science City. The firm was founded by Tang Yang, who serves as CEO. His background includes extensive experience in the robotics industry, having held leadership roles at ABB Robotics, including President of the China R&D Center and President of the Consumer and Service Robotics Business Unit in China. This experience in robotics and automation is central to Bioyond's operational focus.

The company engineers intelligent automation solutions for the life sciences sector by integrating robotics, artificial intelligence, and high-precision visual recognition technologies. Its business-to-business model serves a client base that includes pharmaceutical companies, clinical diagnostics labs, and scientific research institutions. Bioyond has developed a portfolio of modular automation products and comprehensive solutions designed to address repetitive and labor-intensive tasks in laboratory settings, such as liquid handling and sample preparation. The core of its technology rests on three platforms: robotics, automation, and a data and cloud system. This infrastructure allows for the creation of flexible and rapidly deployable automation systems built from a suite of self-developed robots, instrument modules, and intelligent software. An advanced AI and computing engine enables the processing of large datasets to support scientific analysis and decision-making for R&D and production personnel.

Since its inception, Bioyond has secured significant financial backing. Sequoia China Seed Fund was involved from the incubation stage and provided angel financing in early 2021. The company has since completed multiple funding rounds, including a Pre-A round in the same year led by Qiming Venture Capital, and subsequent Series A and A+ rounds co-led by Boyuan Capital and Lilly Asia Fund (LAV), with participation from CICC Qide Fund. By early 2023, the company had raised approximately 300 million RMB. A Series A3 financing round was announced in October 2024, led by Panlin Capital, with continued investment from existing backers like Qiming Venture Capital and Boyuan Capital. These funds are allocated towards product and technology development, platform construction, and market expansion to enhance automation solutions for its target markets.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Pudong, China
Employees
19
Open positions
None listed
Dealroom signal
50.5/100
Industry
Robotics
Sector
Robotics, Hard Tech, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Oct 2024 $28M $110M Pan-Lin Asset Management · Qiming Venture Partners · Boyuan Capital ↗
SERIES AOther financing Apr 2023 $28M $110M Qiming Venture Partners · Shanghai CICC Capital · Lilly Asia Ventures · HongShan ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Bioyond website traffic

Latest recorded traffic for Bioyond is 1.5K monthly website visits, up 59.6% over the last three months. Bioyond's team grew 35.7% over the past year.

Latest monthly visits1.5K 3-month web change+59.6% 1-year team growth+35.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Bioyond in the Pudong ecosystem

Live from Dealroom

The Bioyond office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A6 investors entered at this stage

  • WuXi AppTec
  • Shanghai CICC Capital
  • Lilly Asia Ventures
  • BioTrack Capital
  • Pan-Lin Asset Management
  • Boyuan Capital
Employees 19 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇳 China69.2%
🇺🇸 United States23.1%
🇬🇧 United Kingdom7.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Bioyond on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bioyond’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.